SYNCHRONIZE-CVOT is an event driven cardiovascular outcome trial enrolling patients with preobesity or obesity with cardiovascular disease, chronic kidney disease, or risk factors for cardiovascular disease
Since 2006, Quicksilver Scientific has redefined liposomal supplementation, driven by a mission to solve the bioavailability problem and deliver on the promise of natural health
The study also included exploratory efficacy measurements (forced vital capacity, carbon monoxide diffusing capacity, and 6-minutes' walk distance)
Current areas of scientific investigation include cellular repair signaling studies, connective tissue pathway analysis, extracellular matrix regulation research, copper-dependent signaling investigations, peptide interaction and pathway convergence studies, and multi-peptide coordination research
R., & Yuneva, M
Unlike earlier compounds such as GHRP-6, GHRP-2, and hexarelin, ipamorelin stimulates GH release without producing significant elevations in cortisol, prolactin, or adrenocorticotropic hormone (ACTH)
